Feng S, Kong R, Wang C, Hao Q, et al. A highly selective and orally bioavailable casein kinase 1 alpha degrader through p53 signaling pathway targets B-cell lymphoma cells. Leukemia 2025 May 27. doi: 10.1038/s41375-025-02647.
PMID: 40425803